544738 — Speciality Medicines Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.25bn
- IN₹1.31bn
- IN₹752.85m
Annual cashflow statement for Speciality Medicines, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 21.4 | 29.5 | 45.6 | 86.9 | 130 |
| Depreciation | |||||
| Non-Cash Items | 0.391 | 3.5 | 6.45 | 5.38 | 13 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14.8 | -78.1 | -102 | -159 | -158 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 8.06 | -42.1 | -48 | -64.3 | -12.8 |
| Capital Expenditures | -20.9 | -0.797 | -0.252 | -6.07 | -0.08 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.41 | 1.11 | — | -8.24 | -28.3 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -23.3 | 0.317 | -0.252 | -14.3 | -28.3 |
| Financing Cash Flow Items | -0.265 | -3.42 | -6.05 | 49.5 | 239 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16 | 43.7 | 48.1 | 84.6 | 278 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.768 | 1.85 | -0.127 | 5.97 | 237 |